INTELLIA THERAPEUTICS, INC. (NTLA) Net income 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$412.7MFY2025 · since FY2016: -$31.6M → -$412.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$412.7M | +20.5% |
| FY2024 | -$519.0M | -7.9% |
| FY2023 | -$481.2M | -1.5% |
| FY2022 | -$474.2M | -77.0% |
| FY2021 | -$267.9M | -99.6% |
| FY2020 | -$134.2M | +71.7% |
| FY2019 | -$474.2M | -455.6% |
| FY2018 | -$85.3M | -26.4% |
| FY2017 | -$67.5M | -113.5% |
| FY2016 | -$31.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice